Cancer Treatment Reviews
Volume 36, Issue 3 , Pages 235-248 , May 2010

Esophagogastric cancer: Targeted agents

  • Geoffrey Y. Ku

      Affiliations

    • Ludwig Center for Cancer Immunotherapy, Department of Medicine, Memorial Sloan-Kettering Cancer Center, United States
    • ,
  • David H. Ilson

      Affiliations

    • Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center 1275 York Avenue, New York, NY 10065, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 212 639 8306; fax: +1 212 717 3320.

Received 23 September 2009 ,Revised 9 December 2009 ,Accepted 14 December 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(09)00191-1

doi: 10.1016/j.ctrv.2009.12.009

Cancer Treatment Reviews
Volume 36, Issue 3 , Pages 235-248 , May 2010

Article Tools

* Image Usage & Resolution